Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma

Wagner, 1960, Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province, Br. J. Ind. Med., 17, 260 Stanton, 1972, Mechanisms of mesothelioma induction with asbestos and fibrous glass, J. Natl. Cancer Inst., 48, 797 Toyokuni, 2009, Mechanisms of asbestos-induced carcinogenesis, Nagoya J. Med. Sci., 71, 1 IARC, WHO. Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite, and anthophyllite). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens; Part C: Arsenic, Metals, Fibres, and Dusts. Lyon, France; 2012: pp. 219–309. Takagi, 2008, Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube, J. Toxicol. Sci., 33, 105, 10.2131/jts.33.105 Nagai, 2011, Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis, Proc. Natl. Acad. Sci. USA, 108, E1330, 10.1073/pnas.1110013108 Toyokuni, 2013, Genotoxicity and carcinogenicity risk of carbon nanotubes, Adv. Drug Deliv. Rev., 65, 2098, 10.1016/j.addr.2013.05.011 Wang, 2016, Role of hemoglobin and transferrin in multi-wall carbon nanotube-induced mesothelial injury and carcinogenesis, Cancer Sci., 107, 250, 10.1111/cas.12865 Rascoe, 2012, Molecular pathogenesis of malignant mesothelioma, Expert Rev. Mol. Med., 14, e12, 10.1017/erm.2012.6 Chew, 2015, Malignant mesothelioma as an oxidative stress-induced cancer: an update, Free Radic. Biol. Med., 86, 166, 10.1016/j.freeradbiomed.2015.05.002 Ali, 2013, Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia, J. Thorac. Oncol., 8, 1389, 10.1097/JTO.0b013e3182a59f45 Ponta, 2003, CD44: from adhesion molecules to signalling regulators, Nat. Rev. Mol. Cell Biol., 4, 33, 10.1038/nrm1004 Zoller, 2011, CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?, Nat. Rev. Cancer, 11, 254, 10.1038/nrc3023 Penno, 1995, High CD44 expression on human mesotheliomas mediates association with hyaluronan, Cancer J. Sci. Am., 1, 196 Thylen, 1999, Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma, Cancer, 86, 2000, 10.1002/(SICI)1097-0142(19991115)86:10<2000::AID-CNCR17>3.0.CO;2-N Pettersson, 1988, Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma, Chest, 94, 1037, 10.1378/chest.94.5.1037 Creaney, 2013, Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma, Lung Cancer, 82, 491, 10.1016/j.lungcan.2013.09.016 van der Voort, 1995, Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type, Biochem. Biophys. Res. Commun., 214, 137, 10.1006/bbrc.1995.2267 Iida, 1997, Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis, J. Cell Physiol., 171, 152, 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.0.CO;2-N Asplund, 1994, Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells, Cancer Res., 54, 4516 Nasreen, 2002, Low molecular weight hyaluronan induces malignant mesothelioma cell (MMC) proliferation and haptotaxis: role of CD44 receptor in MMC proliferation and haptotaxis, Oncol. Res., 13, 71 Cortes-Dericks, 2014, Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity, BMC Cancer, 14, 304, 10.1186/1471-2407-14-304 Ishimoto, 2011, CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth, Cancer Cell, 19, 387, 10.1016/j.ccr.2011.01.038 Warzecha, 2009, ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing, Mol. Cell, 33, 591, 10.1016/j.molcel.2009.01.025 Yae, 2012, Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell, Nat. Commun., 3, 883, 10.1038/ncomms1892 Usami, 2006, Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients, Cancer Sci., 97, 387, 10.1111/j.1349-7006.2006.00184.x Taniguchi, 2007, Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32, Cancer Sci., 98, 438, 10.1111/j.1349-7006.2006.00386.x Murakami, 2011, LATS2 is a tumor suppressor gene of malignant mesothelioma, Cancer Res., 71, 873, 10.1158/0008-5472.CAN-10-2164 Sekido, 2011, Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation, Pathol. Int., 61, 331, 10.1111/j.1440-1827.2011.02666.x Tanabe, 1993, Expression of CD44R1 adhesion molecule in colon carcinomas and metastases, Lancet, 341, 725, 10.1016/0140-6736(93)90490-8 Rall, 1995, CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma, Cancer Res., 55, 1831 Muramaki, 2004, Over expression of CD44V8-10 in human bladder cancer cells decreases their interaction with hyaluronic acid and potentiates their malignant progression, J. Urol., 171, 426, 10.1097/01.ju.0000093446.54115.b6 Yoshikawa, 2013, xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma, Cancer Res., 73, 1855, 10.1158/0008-5472.CAN-12-3609-T Zeilstra, 2013, Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling, Oncogene, 33, 665, 10.1038/onc.2012.611 Nagano, 2013, Redox regulation in stem-like cancer cells by CD44 variant isoforms, Oncogene, 32, 5191, 10.1038/onc.2012.638 Lau, 2014, CD44v8-10 is a cancer-specific marker for gastric cancer stem cells, Cancer Res., 74, 2630, 10.1158/0008-5472.CAN-13-2309 Barker, 2010, Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro, Cell Stem Cell, 6, 25, 10.1016/j.stem.2009.11.013 Jiang, 2014, Connective tissue growth factor and beta-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma, J. Pathol., 233, 402, 10.1002/path.4377 Uematsu, 2003, Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin, Cancer Res., 63, 4547 Mazieres, 2005, Wnt2 as a new therapeutic target in malignant pleural mesothelioma, Int. J. Cancer, 117, 326, 10.1002/ijc.21160 Kuniyasu, 2001, Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3, Clin. Cancer Res., 7, 4067 Wang, 2011, Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance, Am. J. Pathol., 178, 956, 10.1016/j.ajpath.2010.11.077 Mulder, 1994, Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins, Lancet, 344, 1470, 10.1016/S0140-6736(94)90290-9 Yamamichi, 1998, Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer, Int. J. Cancer, 79, 256, 10.1002/(SICI)1097-0215(19980619)79:3<256::AID-IJC8>3.0.CO;2-O Yamaguchi, 2002, Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis, J. Surg. Oncol., 79, 230, 10.1002/jso.10082 Khan, 2005, Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation, Clin. Exp. Metastas., 22, 663, 10.1007/s10585-006-9007-0 Ue, 1998, Co-expression of osteopontin and CD44v9 in gastric cancer, Int. J. Cancer, 79, 127, 10.1002/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V Hirata, 2013, CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence, Br. J. Cancer, 109, 379, 10.1038/bjc.2013.314 Katoh, 2015, Cancer stem cell marker in circulating tumor cells: expression of CD44 variant exon 9 is strongly correlated to treatment refractoriness, recurrence and prognosis of human colorectal cancer, Anticancer Res., 35, 239 Sekido, 2013, Molecular pathogenesis of malignant mesothelioma, Carcinogenesis, 34, 1413, 10.1093/carcin/bgt166 Zhang, 2010, The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals, Dev. Cell, 19, 27, 10.1016/j.devcel.2010.06.015 Mizuno, 2012, YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes, Oncogene, 31, 5117, 10.1038/onc.2012.5 Seishima, 2015, Ink4a/Arf-dependent loss of parietal cells induced by oxidative stress promotes CD44-dependent gastric tumorigenesis, Cancer Prev. Res., 8, 492, 10.1158/1940-6207.CAPR-15-0025-T Yae, 2012, Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell, Nat. Commun., 3, 883, 10.1038/ncomms1892 Lu, 2009, Regulation of glutathione synthesis, Mol. Asp. Med., 30, 42, 10.1016/j.mam.2008.05.005 Tajima, 2010, Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells, Oncogene, 29, 1941, 10.1038/onc.2009.478 Toyokuni, 2009, Role of iron in carcinogenesis: cancer as a ferrotoxic disease, Cancer Sci., 100, 9, 10.1111/j.1349-7006.2008.01001.x Nagai, 2011, Asbestos surface provides a niche for oxidative modification, Cancer Sci., 102, 2118, 10.1111/j.1349-7006.2011.02087.x Jiang, 2012, Iron overload signature in chrysotile-induced malignant mesothelioma, J. Pathol., 228, 366, 10.1002/path.4075 Toyokuni, 2016, Oxidative stress as an iceberg in carcinogenesis and cancer biology, Arch. Biochem. Biophys., 595, 46, 10.1016/j.abb.2015.11.025 Toyokuni, 2014, Iron and thiols as two major players in carcinogenesis: friends or foes?, Front. Pharmacol., 5, 200, 10.3389/fphar.2014.00200